Seminal biomarkers for the evaluation of male infertility

Asian Journal of Andrology

Volumn 18, Issue 3, 2016, Pages 426-433

  Bieniek, Jared M ^a   Drabovich, Andrei P ^b,c   Lo, Kirk C ^d  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

assisted reproductive techniques; diagnosis; male infertility, semen

Indexed keywords

BIOLOGICAL MARKER; DNA; PEPTIDES AND PROTEINS; PROTEIN ACRV1; PROTEIN ECM1; PROTEIN TEX101; RNA; SPERM ANTIBODY; UNCLASSIFIED DRUG; ACRV1 PROTEIN, HUMAN; ANTIBODY; ECM1 PROTEIN, HUMAN; MEMBRANE PROTEIN; NYD-SP8 PROTEIN, HUMAN; SCLEROPROTEIN;

AZOOSPERMIA; DNA FRAGMENTATION; EPIGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENOMICS; HUMAN; MALE INFERTILITY; METABOLITE; METABOLOMICS; PROTEIN DETERMINATION; PROTEOMICS; REVIEW; SEMINAL PLASMA; TRANSCRIPTOMICS; GENE EXPRESSION PROFILING; GENETIC EPIGENESIS; GENETICS; MALE; METABOLISM; SPERM;

ANTIBODIES; BIOMARKERS; DNA; DNA FRAGMENTATION; EPIGENESIS, GENETIC; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFERTILITY, MALE; MALE; MEMBRANE PROTEINS; METABOLOMICS; PROTEOMICS; RNA; SEMEN;

EID: 84969792543     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.4103/1008-682X.175781     Document Type: Review

References (118)

1. Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, et al. International committee for monitoring assisted reproductive technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril 2009; 92: 1520-4.
2. Mosher WD, Pratt WF. Fecundity and infertility in the United States: incidence and trends. Fertil Steril 1991; 56: 192-3.
3. Thonneau P, Marchand S, Tallec A, Ferial ML, Ducot B, et al. Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988-1989). Hum Reprod 1991; 6: 811-6.
4. Jarow J, Sigman M, Kolettis PN, Lipshultz LR, McClure D, et al. The Optimal Evaluation of the Infertile Male: AUA Best Practice Statement 2010. Availble from https://www.auanet.org/common/pdf/education/clinical-guidance/Male-Infertility-d.pdf. [Last accessed on 2015 Aug 03].
5. Guzick DS, Overstreet JW, Factor-Litvak P, Brazil CK, Nakajima ST, et al. Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med 2001; 345: 1388-93.
6. World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen. 5 th ed. Geneva: World Health Organization 2010.
7. Murray KS, James A, McGeady JB, Reed ML, Kuang WW, et al. The effect of the new 2010 World Health Organization criteria for semen analyses on male infertility. Fertil Steril 2012; 98: 1428-31.
8. Drabovich AP, Saraon P, Jarvi K, Diamandis EP. Seminal plasma as a diagnostic fluid for male reproductive system disorders. Nat Rev Urol 2014; 11: 278-88.
9. Kovac JR, Pastuszak AW, Lamb DJ. The use of genomics, proteomics, and metabolomics in identifying biomarkers of male infertility. Fertil Steril 2013; 99: 998-1007.
10. Keel BA. Within- And between-subject variation in semen parameters in infertile men and normal semen donors. Fertil Steril 2006; 85: 128-34.
11. Francavilla F, Barbonetti A, Necozione S, Santucci R, Cordeschi G, et al. Within-subject variation of seminal parameters in men with infertile marriages. Int J Androl 2007; 30: 174-81.
12. Leushuis E, van der Steeg JW, Steures P, Repping S, Bossuyt PM, et al. Reproducibility and reliability of repeated semen analyses in male partners of subfertile couples. Fertil Steril 2010; 94: 2631-5.
13. Castilla JA, Alvarez C, Aguilar J, Gonzalez-Varea C, Gonzalvo MC, et al. Influence of analytical and biological variation on the clinical interpretation of seminal parameters. Hum Reprod 2006; 21: 847-51.
14. Menkveld R, Stander FS, Kotze TJ, Kruger TF, van Zyl JA. The evaluation of morphological characteristics of human spermatozoa according to stricter criteria. Hum Reprod 1990; 5: 586-92.
15. Taravati A, Tohidi F. Association between seminal plasma zinc level and asthenozoospermia: a meta-Analysis study. Andrologia 2015. doi: 10.1111/and. 12494. [Epub ahead of print].
16. Marzec-Wroblewska U, Kaminski P, Lakota P, Szymanski M, Wasilow K, et al. The employment of IVF techniques for establishment of sodium, copper and selenium impact upon human sperm quality. Reprod Fertil Dev 2015; doi: 10.1071/RD15041. [Epub ahead of print].
17. Jequier AM. Semen analysis: a new manual and its application to the understanding of semen and its pathology. Asian J Androl 2010; 12: 11-3.
18. Nallella KP, Sharma RK, Aziz N, Agarwal A. Significance of sperm characteristics in the evaluation of male infertility. Fertil Steril 2006; 85: 629-34.
19. Wilson L. Sperm agglutinins in human semen and blood. Proc Soc Exp Biol Med 1954; 85: 652-5.
20. Mital P, Hinton BT, Dufour JM. The blood-Testis and blood-epididymis barriers are more than just their tight junctions. Biol Reprod 2011; 84: 851-8.
21. Jarow JP, Sanzone JJ. Risk factors for male partner antisperm antibodies. J Urol 1992; 148: 1805-7.
22. Lee R, Goldstein M, Ullery BW, Ehrlich J, Soares M, et al. Value of serum antisperm antibodies in diagnosing obstructive azoospermia. J Urol 2009; 181: 264-9.
23. Hellstrom WJ, Samuels SJ, Waits AB, Overstreet JW. A comparison of the usefulness of SpermMar and immunobead tests for the detection of antisperm antibodies. Fertil Steril 1989; 52: 1027-31.
24. Chiu WW, Chamley LW. Clinical associations and mechanisms of action of antisperm antibodies. Fertil Steril 2004; 82: 529-35.
25. Munuce MJ, Berta CL, Pauluzzi F, Caille AM. Relationship between antisperm antibodies, sperm movement, and semen quality. Urol Int 2000; 65: 200-3.
26. Leushuis E, van der Steeg JW, Steures P, Repping S, Schols W, et al. Immunoglobulin G antisperm antibodies and prediction of spontaneous pregnancy. Fertil Steril 2009; 92: 1659-65.
27. Haas GG Jr., Manganiello P. A double-blind, placebo-controlled study of the use of methylprednisolone in infertile men with sperm-Associated immunoglobulins. Fertil Steril 1987; 47: 295-301.
28. Bals-Pratsch M, Doren M, Karbowski B, Schneider HP, Nieschlag E. Cyclic corticosteroid immunosuppression is unsuccessful in the treatment of sperm antibody-related male infertility: a controlled study. Hum Reprod 1992; 7: 99-104.
29. Aitken RJ, De Iuliis GN, Finnie JM, Hedges A, McLachlan RI. Analysis of the relationships between oxidative stress, DNA damage and sperm vitality in a patient population: development of diagnostic criteria. Hum Reprod 2010; 25: 2415-26.
30. Lewis SE, John Aitken R, Conner SJ, Iuliis GD, Evenson DP, et al. The impact of sperm DNA damage in assisted conception and beyond: recent advances in diagnosis and treatment. Reprod Biomed Online 2013; 27: 325-37.
31. Zini A, Bielecki R, Phang D, Zenzes MT. Correlations between two markers of sperm DNA integrity, DNA denaturation and DNA fragmentation, in fertile and infertile men. Fertil Steril 2001; 75: 674-7.
32. Evenson DP, Jost LK, Marshall D, Zinaman MJ, Clegg E, et al. Utility of the sperm chromatin structure assay as a diagnostic and prognostic tool in the human fertility clinic. Hum Reprod 1999; 14: 1039-49.
33. Spano M, Bonde JP, Hjollund HI, Kolstad HA, Cordelli E, et al. Sperm chromatin damage impairs human fertility. The Danish First Pregnancy Planner Study Team. Fertil Steril 2000; 73: 43-50.
34. Evenson DP, Wixon R. Data analysis of two in vivo fertility studies using sperm chromatin structure assay-derived DNA fragmentation index vs. pregnancy outcome. Fertil Steril 2008; 90: 1229-31.
35. Evenson D, Wixon R. Meta-Analysis of sperm DNA fragmentation using the sperm chromatin structure assay. Reprod Biomed Online 2006; 12: 466-72.
36. Robinson L, Gallos ID, Conner SJ, Rajkhowa M, Miller D, et al. The effect of sperm DNA fragmentation on miscarriage rates: a systematic review and meta-Analysis. Hum Reprod 2012; 27: 2908-17.
37. Gharagozloo P, Aitken RJ. The role of sperm oxidative stress in male infertility and the significance of oral antioxidant therapy. Hum Reprod 2011; 26: 1628-40.
38. Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile male: a committee opinion. Fertil Steril 2015; 103: e18-25.
39. Agarwal A, Sharma RK, Nallella KP, Thomas AJ Jr., Alvarez JG, et al. Reactive oxygen species as an independent marker of male factor infertility. Fertil Steril 2006; 86: 878-85.
40. Ko EY, Sabanegh ES Jr., Agarwal A. Male infertility testing: reactive oxygen species and antioxidant capacity. Fertil Steril 2014; 102: 1518-27.
41. Agarwal A, Nallella KP, Allamaneni SS, Said TM. Role of antioxidants in treatment of male infertility: an overview of the literature. Reprod Biomed Online 2004; 8: 616-27.
42. Lombardo F, Sansone A, Romanelli F, Paoli D, Gandini L, et al. The role of antioxidant therapy in the treatment of male infertility: an overview. Asian J Androl 2011; 13: 690-7.
43. Sarrate Z, Blanco J, Anton E, Egozcue S, Egozcue J, et al. FISH studies of chromosome abnormalities in germ cells and its relevance in reproductive counseling. Asian J Androl 2005; 7: 227-36.
44. Hwang K, Weedin JW, Lamb DJ. The use of fluorescent in situ hybridization in male infertility. Ther Adv Urol 2010; 2: 157-69.
45. Martin RH, Balkan W, Burns K, Rademaker AW, Lin CC, et al. The chromosome constitution of 1000 human spermatozoa. Hum Genet 1983; 63: 305-9.
46. Brandriff B, Gordon L, Ashworth L, Watchmaker G, Moore D 2 nd, et al. Chromosomes of human sperm: variability among normal individuals. Hum Genet 1985; 70: 18-24.
47. Bernardini LM, Costa M, Bottazzi C, Gianaroli L, Magli MC, et al. Sperm aneuploidy and recurrent pregnancy loss. Reprod Biomed Online 2004; 9: 312-20.
48. Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile female: a committee opinion. Fertil Steril 2015; 103: e44-50.
49. Carrell DT, Emery BR, Hammoud S. Altered protamine expression and diminished spermatogenesis: what is the link?. Hum Reprod Update 2007; 13: 313-27.
50. Carrell DT, Liu L. Altered protamine 2 expression is uncommon in donors of known fertility, but common among men with poor fertilizing capacity, and may reflect other abnormalities of spermiogenesis. J Androl 2001; 22: 604-10.
51. Rajender S, Avery K, Agarwal A. Epigenetics, spermatogenesis and male infertility. Mutat Res 2011; 727: 62-71.
52. Nanassy L, Carrell DT. Abnormal methylation of the promoter of CREM is broadly associated with male factor infertility and poor sperm quality but is improved in sperm selected by density gradient centrifugation. Fertil Steril 2011; 95: 2310-4.
53. Poplinski A, Tuttelmann F, Kanber D, Horsthemke B, Gromoll J. Idiopathic male infertility is strongly associated with aberrant methylation of MEST and IGF2/H19 ICR1. Int J Androl 2010; 33: 642-9.
54. Hammoud SS, Purwar J, Pflueger C, Cairns BR, Carrell DT. Alterations in sperm DNA methylation patterns at imprinted loci in two classes of infertility. Fertil Steril 2010; 94: 1728-33.
55. Kobayashi H, Sato A, Otsu E, Hiura H, Tomatsu C, et al. Aberrant DNA methylation of imprinted loci in sperm from oligospermic patients. Hum Mol Genet 2007; 16: 2542-51.
56. Platts AE, Dix DJ, Chemes HE, Thompson KE, Goodrich R, et al. Success and failure in human spermatogenesis as revealed by teratozoospermic RNAs. Hum Mol Genet 2007; 16: 763-73.
57. Garrido N, Martinez-Conejero JA, Jauregui J, Horcajadas JA, Simon C, et al. Microarray analysis in sperm from fertile and infertile men without basic sperm analysis abnormalities reveals a significantly different transcriptome. Fertil Steril 2009; 91: 1307-10.
58. Krawetz SA, Kruger A, Lalancette C, Tagett R, Anton E, et al. A survey of small RNAs in human sperm. Hum Reprod 2011; 26: 3401-12.
59. Jodar M, Selvaraju S, Sendler E, Diamond MP, Krawetz SA, et al. The presence, role and clinical use of spermatozoal RNAs. Hum Reprod Update 2013; 19: 604-24.
60. Jodar M, Sendler E, Moskovtsev SI, Librach CL, Goodrich R, et al. Absence of sperm RNA elements correlates with idiopathic male infertility. Sci Transl Med 2015; 7: 295-6.
61. Salas-Huetos A, Blanco J, Vidal F, Godo A, Grossmann M, et al. Spermatozoa from patients with seminal alterations exhibit a differential micro-ribonucleic acid profile. Fertil Steril 2015; 104: 591-601.
62. Gray S, Huggins C. Electrophoretic analysis of human semen. Exp Biol Med 1942; 50: 351-3.
63. Batruch I, Lecker I, Kagedan D, Smith CR, Mullen BJ, et al. Proteomic analysis of seminal plasma from normal volunteers and post-vasectomy patients identifies over 2000 proteins and candidate biomarkers of the urogenital system. J Proteome Res 2011; 10: 941-53.
64. Wang J, Wang J, Zhang HR, Shi HJ, Ma D, et al. Proteomic analysis of seminal plasma from asthenozoospermia patients reveals proteins that affect oxidative stress responses and semen quality. Asian J Androl 2009; 11: 484-91.
65. Diamandis EP, Arnett WP, Foussias G, Pappas H, Ghandi S, et al. Seminal plasma biochemical markers and their association with semen analysis findings. Urology 1999; 53: 596-603.
66. Rolland AD, Lavigne R, Dauly C, Calvel P, Kervarrec C, et al. Identification of genital tract markers in the human seminal plasma using an integrative genomics approach. Hum Reprod 2013; 28: 199-209.
67. Davalieva K, Kiprijanovska S, Noveski P, Plaseski T, Kocevska B, et al. Proteomic analysis of seminal plasma in men with different spermatogenic impairment. Andrologia 2012; 44: 256-64.
68. Milardi D, Grande G, Vincenzoni F, Messana I, Pontecorvi A, et al. Proteomic approach in the identification of fertility pattern in seminal plasma of fertile men. Fertil Steril 2012; 97: 67-73.
69. Cadavid JA, Alvarez A, Markert UR, Cardona Maya W. Differential protein expression in seminal plasma from fertile and infertile males. J Hum Reprod Sci 2014; 7: 206-11.
70. Yamakawa K, Yoshida K, Nishikawa H, Kato T, Iwamoto T. Comparative analysis of interindividual variations in the seminal plasma proteome of fertile men with identification of potential markers for azoospermia in infertile patients. J Androl 2007; 28: 858-65.
71. Ronquist G, Brody I. The prostasome: its secretion and function in man. Biochim Biophys Acta 1985; 822: 203-18.
72. Utleg AG, Yi EC, Xie T, Shannon P, White JT, et al. Proteomic analysis of human prostasomes. Prostate 2003; 56: 150-61.
73. Poliakov A, Spilman M, Dokland T, Amling CL, Mobley JA. Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen. Prostate 2009; 69: 159-67.
74. Thimon V, Frenette G, Saez F, Thabet M, Sullivan R. Protein composition of human epididymosomes collected during surgical vasectomy reversal: a proteomic and genomic approach. Hum Reprod 2008; 23: 1698-707.
75. Sandvig K, Llorente A. Proteomic analysis of microvesicles released by the human prostate cancer cell line PC-3. Mol Cell Proteomics 2012; 11: M111.012914.
76. Drabovich AP, Martinez-Morillo E, Diamandis EP. Toward an integrated pipeline for protein biomarker development. Biochim Biophys Acta 2015; 1854: 677-86.
77. Drabovich AP, Pavlou MP, Batruch I, Diamandis EP. Proteomic and mass spectrometry technologies for protein biomarker discovery. In: Isaaq HJ, Veenstra TD, editors. Proteomic and Metabolomic Approaches to Biomarker Discovery. Amsterdam: Elsevier 2013. p. 472.
78. Carpi A, Sabanegh E, Mechanick J. Controversies in the management of nonobstructive azoospermia. Fertil Steril 2009; 91: 963-70.
79. Tsametis C, Mintziori G, Iliadou PK, Tarlatzis BC, Papadimas I, et al. Dynamic endocrine test of inhibin B and anti-Mullerian hormone in men with non-obstructive azoospermia. Gynecol Endocrinol 2011; 27: 661-5.
80. Muttukrishna S, Yussoff H, Naidu M, Barua J, Arambage K, et al. Serum anti-Mullerian hormone and inhibin B in disorders of spermatogenesis. Fertil Steril 2007; 88: 516-8.
81. Madani AH, Falahatkar S, Heidarzadeh A, Roshan ZA, Sazgari E, et al. Sensitivity and specificity of serum FSH and testis size in predicting the existence of spermatogenesis in azoospermic infertile men. Andrologia 2012; 44: 205-9.
82. Batruch I, Smith CR, Mullen BJ, Grober E, Lo KC, et al. Analysis of seminal plasma from patients with non-obstructive azoospermia and identification of candidate biomarkers of male infertility. J Proteome Res 2012; 11: 1503-11.
83. Pilch B, Mann M. Large-scale and high-confidence proteomic analysis of human seminal plasma. Genome Biol 2006; 7: R40.
84. Rolland AD, Lavigne R, Dauly C, Calvel P, Kervarrec C, et al. Identification of genital tract markers in the human seminal plasma using an integrative genomics approach. Hum Reprod 2012; 28: 199-209.
85. Heshmat SM, Mullen JB, Jarvi KA, Soosaipillai A, Diamandis EP, et al. Seminal plasma lipocalin-Type prostaglandin D synthase: a potential new marker for the diagnosis of obstructive azoospermia. J Urol 2008; 179: 1077-80.
86. Drabovich AP, Jarvi K, Diamandis EP. Verification of male infertility biomarkers in seminal plasma by multiplex selected reaction monitoring assay. Mol Cell Proteomics 2011; 10: M110.004127.
87. Coppola MA, Klotz KL, Kim KA, Cho HY, Kang J, et al. SpermCheck Fertility, an immunodiagnostic home test that detects normozoospermia and severe oligozoospermia. Hum Reprod 2010; 25: 853-61.
88. Klotz KL, Coppola MA, Labrecque M, Brugh VM 3 rd, Ramsey K, et al. Clinical and consumer trial performance of a sensitive immunodiagnostic home test that qualitatively detects low concentrations of sperm following vasectomy. J Urol 2008; 180: 2569-76.
89. Freour T, Com E, Barriere P, Bouchot O, Jean M, et al. Comparative proteomic analysis coupled with conventional protein assay as a strategy to identify predictors of successful testicular sperm extraction in patients with non-obstructive azoospermia. Andrology 2013; 1: 414-20.
90. Drabovich AP, Dimitromanolakis A, Saraon P, Soosaipillai A, Batruch I, et al. Differential diagnosis of azoospermia with proteomic biomarkers ECM1 and TEX101 quantified in seminal plasma. Sci Transl Med 2013; 5: 212ra160.
91. Korbakis D, Brinc D, Schiza C, Soosaipillai A, Jarvi K, et al. Immunocapture-selected reaction monitoring screening facilitates the development of ELISA for the measurement of native TEX101 in biological fluids. Mol Cell Proteomics 2015; 14: 1517-26.
92. Fijak M, Zeller T, Huys T, Klug J, Wahle E, et al. Autoantibodies against protein disulfide isomerase ER-60 are a diagnostic marker for low-grade testicular inflammation. Hum Reprod 2014; 29: 2382-92.
93. Veltman-Verhulst SM, Cohlen BJ, Hughes E, Heineman MJ. Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev 2012; 9: CD001838.
94. Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2012 Assisted Reproductive Technology National Summary Report. Atlanta, GA: US Dept of Health and Human Services 2014.
95. Sunderam S, Kissin DM, Crawford SB, Folger SG, Jamieson DJ, et al. Assisted reproductive technology surveillance - United States, 2012. MMWR Surveill Summ 2015; 64 Suppl 6: 1-29.
96. de Mouzon J, Goossens V, Bhattacharya S, Castilla JA, Ferraretti AP, et al. Assisted reproductive technology in Europe, 2007: results generated from European registers by ESHRE. Hum Reprod 2012; 27: 954-66.
97. Muller CH. Rationale, interpretation, validation, and uses of sperm function tests. J Androl 2000; 21: 10-30.
98. Zaneveld LJ, De Jonge CJ, Anderson RA, Mack SR. Human sperm capacitation and the acrosome reaction. Hum Reprod 1991; 6: 1265-74.
99. Katsuki T, Hara T, Ueda K, Tanaka J, Ohama K. Prediction of outcomes of assisted reproduction treatment using the calcium ionophore-induced acrosome reaction. Hum Reprod 2005; 20: 469-75.
100. Bronson RA, Peresleni T, Golightly M. Progesterone promotes the acrosome reaction in capacitated human spermatozoa as judged by flow cytometry and CD46 staining. Mol Hum Reprod 1999; 5: 507-12.
101. Oehninger S, Franken DR, Ombelet W. Sperm functional tests. Fertil Steril 2014; 102: 1528-33.
102. Gvakharia MO, Lipshultz LI, Lamb DJ. Human sperm microinjection into hamster oocytes: a new tool for training and evaluation of the technical proficiency of intracytoplasmic sperm injection. Fertil Steril 2000; 73: 395-401.
103. Zini A, Fahmy N, Belzile E, Ciampi A, Al-Hathal N, et al. Antisperm antibodies are not associated with pregnancy rates after IVF and ICSI: systematic review and meta-Analysis. Hum Reprod 2011; 26: 1288-95.
104. Collins JA, Barnhart KT, Schlegel PN. Do sperm DNA integrity tests predict pregnancy with in vitro fertilization?. Fertil Steril 2008; 89: 823-31.
105. Zini A, Sigman M. Are tests of sperm DNA damage clinically useful?. Pros and cons. J Androl 2009; 30: 219-29.
106. Payne JF, Raburn DJ, Couchman GM, Price TM, Jamison MG, et al. Redefining the relationship between sperm deoxyribonucleic acid fragmentation as measured by the sperm chromatin structure assay and outcomes of assisted reproductive techniques. Fertil Steril 2005; 84: 356-64.
107. Zini A. Are sperm chromatin and DNA defects relevant in the clinic?. Syst Biol Reprod Med 2011; 57: 78-85.
108. Zini A, Boman JM, Belzile E, Ciampi A. Sperm DNA damage is associated with an increased risk of pregnancy loss after IVF and ICSI: systematic review and meta-Analysis. Hum Reprod 2008; 23: 2663-8.
109. Bungum M, Bungum L, Lynch KF, Wedlund L, Humaidan P, et al. Spermatozoa DNA damage measured by sperm chromatin structure assay (SCSA) and birth characteristics in children conceived by IVF and ICSI. Int J Androl 2012; 35: 485-90.
110. Agarwal A, Allamaneni SS, Nallella KP, George AT, Mascha E. Correlation of reactive oxygen species levels with the fertilization rate after in vitro fertilization: a qualified meta-Analysis. Fertil Steril 2005; 84: 228-31.
111. Hammadeh ME, Al Hasani S, Rosenbaum P, Schmidt W, Fischer Hammadeh C. Reactive oxygen species, total antioxidant concentration of seminal plasma and their effect on sperm parameters and outcome of IVF/ICSI patients. Arch Gynecol Obstet 2008; 277: 515-26.
112. Petit FM, Frydman N, Benkhalifa M, Le Du A, Aboura A, et al. Could sperm aneuploidy rate determination be used as a predictive test before intracytoplasmic sperm injection?. J Androl. 2005; 26: 235-41.
113. Aoki VW, Liu L, Jones KP, Hatasaka HH, Gibson M, et al. Sperm protamine 1/protamine 2 ratios are related to in vitro fertilization pregnancy rates and predictive of fertilization ability. Fertil Steril 2006; 86: 1408-15.
114. Zhu Y, Wu Y, Jin K, Lu H, Liu F, et al. Differential proteomic profiling in human spermatozoa that did or did not result in pregnancy via IVF and AID. Proteomics Clin Appl 2013; 7: 850-8.
115. Azpiazu R, Amaral A, Castillo J, Estanyol JM, Guimera M, et al. High-Throughput sperm differential proteomics suggests that epigenetic alterations contribute to failed assisted reproduction. Hum Reprod 2014; 29: 1225-37.
116. Duncan MW, Thompson HS. Proteomics of semen and its constituents. Proteomics Clin Appl 2007; 1: 861-75.
117. Jodar M, Sendler E, Krawetz SA. The protein and transcript profiles of human semen. Cell Tissue Res 2016; 363: 85-96.
118. Detrick B, Hamilton RG, Folds JD. Manual of Molecular and Clinical Laboratory Immunology. 7 th ed. Washington, DC: ASM Press 2006.